Whitehawk Therapeutics, Inc. (WHWK) Tops Q1 EPS by 218c

Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q1 EPS of $1.83, $2.18 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $7.14 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• Nutex Health reports unauthorized access to company network data
• Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00